Three faces of recombination activating gene 1 (RAG1) mutations

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Severe combined immune deficiency (SCID) encompasses genetic disorders affecting T- and B-lymphocyte development.
• Recombination-activating genes (RAG1/2) are essential for VDJ recombination, generating diverse T-cell receptor (TCR) and B-cell receptor (BCR) repertoires.
• Mutations in RAG1/2 genes lead to a spectrum of primary immunodeficiencies, including SCID, Omenn syndrome (OS), and atypical SCID.

Observation:

• This report describes four pediatric patients diagnosed with RAG1 deficiency.
• Two patients presented with classic SCID, characterized by recurrent pneumonia, chronic diarrhea, and failure to thrive.
• One patient exhibited Omenn syndrome with chronic diarrhea, skin rash, and recurrent lower respiratory infections.
• A fourth patient presented with atypical SCID, including Pyoderma gangrenosum (PG), and a novel RAG1 mutation.

Findings:

• RAG1 deficiency manifests in diverse clinical phenotypes, from classic SCID to Omenn syndrome and atypical presentations.
• The study highlights a novel RAG1 mutation associated with an atypical SCID phenotype including Pyoderma gangrenosum.
• Genetic analysis of RAG1 is crucial for diagnosing and understanding the spectrum of immunodeficiencies.

Implications:

• Understanding RAG1 mutations expands diagnostic capabilities for primary immunodeficiencies.
• Identifying novel mutations aids in predicting disease severity and potential complications.
• This research contributes to the broader knowledge of immune system development and genetic disorders.